Treatment of scleromyxedema with lenalidomide, bortezomib and dexamethasone: A case report and review of the literature

被引：5
作者：
Win, Hninyee [1 ]
Gowin, Krisstina [2 ]
机构：
[1] Univ Arizona, Dept Med, Tucson, AZ USA
[2] Univ Arizona, Dept Hematol & Oncol, Tucson, AZ USA
来源：
CLINICAL CASE REPORTS | 2020年 / 8卷 / 12期
关键词：
bortezomib; lenalidomide; paraproteinemia; plasma cells; scleromyxedema; treatment; STEM-CELL TRANSPLANTATION; HIGH-DOSE DEXAMETHASONE; LICHEN MYXEDEMATOSUS; HYALURONIC-ACID; THALIDOMIDE; COMBINATION; THERAPY; IMMUNOGLOBULIN; PATIENT;
D O I：
10.1002/ccr3.3302
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Scleromyxedema is a rare and progressive disease that currently has no standard treatment. Triplet therapy with lenalidomide, bortezomib, and dexamethasone can be an effective therapy for scleromyxedema, especially in patients with refractory or relapsed disease.
引用
收藏
页码：3042 / 3048
页数：7
相关论文
共 35 条
[1]   Autoimmune/inflammatory syndrome (ASIA) induced by biomaterials injection other than silicone medical grade [J].
Alijotas-Reig, J. ;
Garcia-Gimenez, V. ;
Llurba, E. ;
Vilardell-Tarres, M. .
LUPUS, 2012, 21 (12) :1326-1334
[2]   Scleromyxedema: Successful treatment with thalidomide in two patients [J].
Amini-Adle, Mona ;
Thieulent, Nadege ;
Dalle, Stephane ;
Balme, Brigitte ;
Thomas, Luc .
DERMATOLOGY, 2007, 214 (01) :58-60
[3]   Transient efficacy of double high-dose chemotherapy and autologous peripheral stem cell transplantation, immunoglobulin, thalidomide, and bortezomib in the treatment of scleromyxedema [J].
Ataergin, Selmin ;
Arpaci, Fikret ;
Demiriz, Murat ;
Ozet, Ahmet .
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2008, 9 (04) :271-273
[4]   Anti-inflammatory actions of glucocorticoids: molecular mechanisms [J].
Barnes, PJ .
CLINICAL SCIENCE, 1998, 94 (06) :557-572
[5]   The role of intravenous immunoglobulin therapy in mediating skin fibrosis in tight skin mice [J].
Blank, M ;
Levy, Y ;
Amital, H ;
Shoenfeld, Y .
ARTHRITIS AND RHEUMATISM, 2002, 46 (06) :1689-1690
[6]   Thalidomide and dexamethasone followed by autologous stem cell transplantation for scleromyxoedema [J].
Bos, Reinhard ;
de Waal, Esther G. M. ;
Kuiper, Hilde ;
Hazenberg, Bouke P. C. ;
Vellenga, Edo .
RHEUMATOLOGY, 2011, 50 (10) :1925-1926
[7]   Combination of intravenous immunoglobulins and lenalidomide in the treatment of scleromyxedema [J].
Brunet-Possenti, Florence ;
Hermine, Olivier ;
Marinho, Eduardo ;
Crickx, Beatrice ;
Descamps, Vincent .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2013, 69 (02) :319-320
[8]   The combination of bortezomib and dexamethasone is an efficient therapy for relapsed/refractory scleromyxedema: a rare disease with new clinical insights [J].
Canueto, Javier ;
Labrador, Jorge ;
Roman, Concepcion ;
Santos-Briz, Angel ;
Contreras, Teresa ;
Carmen Gutierrrez, Norma ;
Garcia-Sanz, Ramon .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2012, 88 (05) :450-454
[9]   SCLEROMYXEDEMA [J].
DINNEEN, AM ;
DICKEN, CH .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1995, 33 (01) :37-43
[10]   Intravenous Gammaglobulin and Thalidomide May Be an Effective Therapeutic Combination in Refractory Scleromyxedema: Case Report and Discussion of the Literature [J].
Efthimiou, Petros ;
Blanco, Michelle .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2008, 38 (03) :188-194
1234